Top Markets
Coin of the day
Universal Vision Biotechnology Co., Ltd. Universal Vision Biotechnology Co., Ltd.

Universal Vision Biotechnology Co., Ltd.

3218
Pozycja w akcjach #14903
Universal Vision Biotechnology Co., Ltd., established in 1992 and based in... Universal Vision Biotechnology Co., Ltd., established in 1992 and based in Taipei, Taiwan, manages a network of eye care clinics across both Taiwan and China. The company delivers a comprehensive range of ophthalmic services, encompassing advanced surgical interventions and treatments for various ocular conditions. Its surgical specialties include laser vision correction for common refractive errors such as myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related vision decline). They also perform intraocular lens procedures for presbyopia and cataracts, employing advanced techniques like phacoemulsification and femtosecond laser surgery. Beyond surgical solutions, Universal Vision addresses a wide spectrum of eye health concerns, offering services for myopia control, dry eye syndrome, retinal detachment, macular degeneration, strabismus (crossed eyes), amblyopia (lazy eye), and numerous other ophthalmic ailments. The company further provides a diverse array of vision products and optical aids, including various eyeglass frames, specialized multifocal and progressive lenses for myopia and presbyopia, sunglasses, orthokeratology, rigid gas permeable lenses, and both conventional and colored contact lenses. Nutritional eye supplements are also available. Additional offerings include oculoplastic and micro cosmetic eye surgery, alongside bespoke aesthetic medicine consultations. Furthermore, Universal Vision engages in optometric services, hospital administration, technical advisory roles, and the distribution and rental of medical equipment.
Cena akcji
$4.55
Kapitalizacja rynkowa
$385.27M
Zmiana (1 dzień)
-0.35%
Zmiana (1 rok)
-21.53%
Kraj
TW
Handel Universal Vision Biotechnology Co., Ltd. (3218)

Kategoria

Cena 3218 z kapitalizacją rynkową B
Universal Vision Biotechnology Co., Ltd. Universal Vision Biotechnology Co., Ltd.
3218
$4.55
Kapitalizacja rynkowa Universal Vision Biotechnology Co., Ltd.(3218)
Kapitalizacja rynkowa: $385.27M
Na dzień September 2026 spółka Universal Vision Biotechnology Co., Ltd. ma kapitalizację rynkową wynoszącą $385.27M. Według naszych danych, czyni to Universal Vision Biotechnology Co., Ltd. 14903rd najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Universal Vision Biotechnology Co., Ltd. od 2005 do 2026
3218 w porównaniu do 5 najpopularniejszych stocks
Cena za 3218 Aktywa B Kapitalizacja rynkowa B Wyniki
Universal Vision Biotechnology Co., Ltd. Universal Vision Biotechnology Co., Ltd.
$62,871.76 $385.27M
$5.327T +1,382,529.23%
Universal Vision Biotechnology Co., Ltd. Universal Vision Biotechnology Co., Ltd.
$54,823.04 $385.27M
$4.645T +1,205,527.69%
Universal Vision Biotechnology Co., Ltd. Universal Vision Biotechnology Co., Ltd.
$48,040.90 $385.27M
$4.070T +1,056,379.91%
Universal Vision Biotechnology Co., Ltd. Universal Vision Biotechnology Co., Ltd.
$44,669.04 $385.27M
$3.785T +982,228.55%
Universal Vision Biotechnology Co., Ltd. Universal Vision Biotechnology Co., Ltd.
$32,931.56 $385.27M
$2.790T +724,106.43%